New type of antifungal approved for invasive aspergillosis.
Thompson
C A
CA
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy*; D000077336:Caspofungin; D017277:Drug Approval; D054714:Echinocandins; D006801:Humans; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D014481:United States; D014486:United States Food and Drug Administration
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D000077336:Caspofungin